We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.87B
AUM Growth
+$200M
Cap. Flow
+$90.7M
Cap. Flow %
4.84%
Top 10 Hldgs %
19.32%
Holding
2,614
New
129
Increased
710
Reduced
532
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 6.41%
2 Financials 5.23%
3 Industrials 5.16%
4 Energy 5%
5 Healthcare 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKHS icon
2326
Workhorse Group
WKHS
$33.7M
0
WTRE icon
2327
WisdomTree New Economy Real Estate Fund
WTRE
$15.9M
$3K ﹤0.01%
102
XNTK icon
2328
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
$3K ﹤0.01%
38
XXII
2329
22nd Century Group
XXII
$1.46M
0
CNR
2330
Core Natural Resources Inc
CNR
$4.03B
$3K ﹤0.01%
263
-110
-29% -$1.52K
PDCO
2331
DELISTED
Patterson Companies, Inc.
PDCO
$3K ﹤0.01%
167
HMNF
2332
DELISTED
HMN Financial Inc
HMNF
$3K ﹤0.01%
150
FAM
2333
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$3K ﹤0.01%
300
-544
-64% -$5.97K
LSXMK
2334
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$3K ﹤0.01%
105
NVTA
2335
DELISTED
Invitae Corporation
NVTA
$3K ﹤0.01%
224
RJA
2336
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$3K ﹤0.01%
600
INFO
2337
DELISTED
IHS Markit Ltd. Common Shares
INFO
$3K ﹤0.01%
+50
New +$3.56K
ALXN
2338
DELISTED
Alexion Pharmaceuticals
ALXN
$3K ﹤0.01%
+30
New +$3.21K
AIG.WS
2339
DELISTED
American International Group, Inc.
AIG.WS
$3K ﹤0.01%
358
BMY.RT
2340
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$3K ﹤0.01%
+1,148
New +$2.98K
BDSI
2341
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3K ﹤0.01%
500
-300
-38% -$1.76K
AAOI icon
2342
Applied Optoelectronics
AAOI
$8.77B
$2K ﹤0.01%
225
ABCB icon
2343
Ameris Bancorp
ABCB
$5.93B
$2K ﹤0.01%
65
AGZ icon
2344
iShares Agency Bond ETF
AGZ
$563M
$2K ﹤0.01%
20
AMKR icon
2345
Amkor Technology
AMKR
$12.6B
$2K ﹤0.01%
200
ANSS
2346
DELISTED
Ansys
ANSS
$2K ﹤0.01%
8
ARCO icon
2347
Arcos Dorados Holdings
ARCO
$1.74B
$2K ﹤0.01%
337
+1
+0.3% +$7
ARR
2348
Armour Residential REIT
ARR
$2.32B
$2K ﹤0.01%
30
ASYS icon
2349
Amtech Systems
ASYS
$273M
$2K ﹤0.01%
395
AXDX
2350
DELISTED
Accelerate Diagnostics
AXDX
$2K ﹤0.01%
16

Similar funds

Geneos Wealth Management's Q4 2019 Portfolio in Review

As of Q4 2019, Geneos Wealth Management held 2,614 positions worth $1.87B, up 12% from $1.67B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $90.7M of net new capital in Q4 2019, opening 129 new positions and adding to 710 existing holdings. Its largest new stake was State Street SPDR Portfolio MSCI Global Stock Market ETF: 131,495 shares worth $5.66M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 5.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $16.2M trimmed.

  • Geneos Wealth Management's largest Q4 2019 buy was State Street SPDR Portfolio MSCI Global Stock Market ETF: 131,495 shares worth $5.66M.
  • Geneos Wealth Management added most to Marriott International in Q4 2019, an estimated $13.6M increase.
  • Geneos Wealth Management's biggest Q4 2019 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $16.2M.
  • Geneos Wealth Management fully exited First Trust Consumer Discretionary AlphaDEX Fund in Q4 2019, selling an estimated $48K.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $1.87B portfolio in Q4 2019.
  • Geneos Wealth Management opened 129 new positions and closed 73 in Q4 2019.
  • Geneos Wealth Management's portfolio value rose 12% quarter-over-quarter to $1.87B.

Based on Geneos Wealth Management's 13F filing for Q4 2019, filed 7 Sep 2021.